ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 538,29
-0,30%
Dow Jones
39 110,14
-0,15%
DAX
18 164,06
-0,86%
Brent Oil
86,405
-0,14%
Bitcoin
61 842,87
-1,60%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Protagonist Therapeutics Inc (PTGX)

  7. Protagonist Therapeutics Inc (PTGX) Actualités

PTGX Protagonist Therapeutics Inc

34,975
-0,225 (-0,64%)
Dernière mise à jour : 17:52:46
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Protagonist Therapeutics Inc PTGX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,225 -0,64% 34,975 17:52:46
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
35,61 34,86 35,90 35,20
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
27/6/202423:44PRNUSProtagonist Therapeutics Set to Join S&P SmallCap 600
11/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:46EDGAR2Form 144 - Report of proposed sale of securities
07/5/202422:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:29EDGAR2Form 8-K - Current report
16/4/202415:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:27EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:32EDGAR2Form 144 - Report of proposed sale of securities
29/2/202423:48EDGAR2Form 144 - Report of proposed sale of securities
29/2/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:12EDGAR2Form 8-K - Current report
14/2/202413:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202422:05EDGAR2Form 8-K - Current report
19/1/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202414:01EDGAR2Form 8-K - Current report
12/1/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:25EDGAR2Form 144 - Report of proposed sale of securities
08/1/202414:00EDGAR2Form 8-K - Current report
05/1/202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/11/202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:40EDGAR2Form 8-K - Current report
30/10/202321:30EDGAR2Form 8-K - Current report
23/10/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/8/202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:13EDGAR2Form 8-K - Current report
05/7/202314:00EDGAR2Form 8-K - Current report
03/7/202322:06EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
PTGX
Protagonist Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés